InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Alaunos Therapeutics, Inc.

TCRT Clue Score31
United States Fiscal year ends December CIK 0001107421
$0.79 +0.61% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.79 −55.60% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue6.9Operating income−165.3Net income−165.3EPS, diluted−1.32Fiscal year 2017Revenue6.4 −6.9%Operating income−53.5Net income−54.3EPS, diluted−0.53Fiscal year 2018Revenue0.1 −97.7%Operating income−53.9Net income−53.1EPS, diluted0.96Fiscal year 2019Operating income−57.9Net income−117.8EPS, diluted−0.70Fiscal year 2020Revenue0.0Operating income−80.4Net income−80.0EPS, diluted−0.38Fiscal year 2021Revenue0.4Operating income−77.5Net income−78.8EPS, diluted−0.37Fiscal year 2022Revenue2.9 +634.2%Operating income−35.1Net income−37.7EPS, diluted−2.61Fiscal year 2023Revenue0.0 −99.8%Operating income−34.3Net income−4.7EPS, diluted−21.97Fiscal year 2024Revenue0.0 +100.0%Operating income−4.8Net income−4.7EPS, diluted−2.92Fiscal year 2025Revenue0.0 −50.0%Operating income−4.2Net income−4.2EPS, diluted−2.20
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 6.9 6.4 0.1 n/a 0.0 0.4 2.9 0.0 0.0 0.0
Growth −6.9% −97.7% +634.2% −99.8% +100.0% −50.0%
Operating income −165.3 −53.5 −53.9 −57.9 −80.4 −77.5 −35.1 −34.3 −4.8 −4.2
Net income −165.3 −54.3 −53.1 −117.8 −80.0 −78.8 −37.7 −4.7 −4.7 −4.2
Growth
EPS, diluted −1.32 −0.53 0.96 −0.70 −0.38 −0.37 −2.61 −21.97 −2.92 −2.20

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−2,409.4%Net margin−2,409.2%Free cash flow margin−858.1%Fiscal year 2017Operating margin−837.3%Net margin−850.3%Free cash flow margin−867.2%Fiscal year 2018Operating margin−36,921.9%Net margin−36,381.5%Free cash flow margin−34,189.0%Fiscal year 2019Fiscal year 2020Fiscal year 2021Operating margin−19,484.7%Net margin−19,786.7%Free cash flow margin−16,279.1%Fiscal year 2022Operating margin−1,201.4%Net margin−1,291.2%Free cash flow margin−1,007.8%Fiscal year 2023Operating margin−685,340.0%Net margin−93,580.0%Free cash flow margin−606,780.0%Fiscal year 2024Operating margin−48,120.0%Net margin−46,790.0%Free cash flow margin−49,710.0%Fiscal year 2025Operating margin−84,500.0%Net margin−83,520.0%Free cash flow margin−59,340.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −2,409.4% −837.3% −36,921.9% n/a n/a −19,484.7% −1,201.4% −685,340.0% −48,120.0% −84,500.0%
Net margin −2,409.2% −850.3% −36,381.5% n/a n/a −19,786.7% −1,291.2% −93,580.0% −46,790.0% −83,520.0%
Free cash flow margin −858.1% −867.2% −34,189.0% n/a n/a −16,279.1% −1,007.8% −606,780.0% −49,710.0% −59,340.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−58.3Capital expenditure−0.6Free cash flow−58.9Buybacks−0.0Fiscal year 2017Operating cash flow−54.7Capital expenditure−0.7Free cash flow−55.4Buybacks0.0Fiscal year 2018Operating cash flow−49.5Capital expenditure−0.5Free cash flow−49.9Buybacks−1.6Fiscal year 2019Operating cash flow−40.9Capital expenditure−0.3Free cash flow−41.1Buybacks−0.7Fiscal year 2020Operating cash flow−57.0Capital expenditure−9.8Free cash flow−66.8Fiscal year 2021Operating cash flow−61.5Capital expenditure−3.3Free cash flow−64.8Buybacks0.0Fiscal year 2022Operating cash flow−29.2Capital expenditure−0.2Free cash flow−29.4Buybacks−0.0Fiscal year 2023Operating cash flow−30.1Capital expenditure−0.2Free cash flow−30.3Buybacks0.0Fiscal year 2024Operating cash flow−5.0Capital expenditure0.0Free cash flow−5.0Fiscal year 2025Operating cash flow−2.9Capital expenditure−0.1Free cash flow−3.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −58.3 −54.7 −49.5 −40.9 −57.0 −61.5 −29.2 −30.1 −5.0 −2.9
Capital expenditure −0.6 −0.7 −0.5 −0.3 −9.8 −3.3 −0.2 −0.2 0.0 −0.1
Free cash flow −58.9 −55.4 −49.9 −41.1 −66.8 −64.8 −29.4 −30.3 −5.0 −3.0
Growth
Buybacks −0.0 0.0 −1.6 −0.7 n/a 0.0 −0.0 0.0 n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash81.1Shareholders’ equity−77.3Fiscal year 2017Cash70.9Shareholders’ equity−96.8Fiscal year 2018Cash61.7Shareholders’ equity85.6Fiscal year 2019Cash79.7Shareholders’ equity95.0Fiscal year 2020Cash115.1Total debt0.0Net cash (debt)115.1Shareholders’ equity124.0Debt to equity0.00Fiscal year 2021Cash76.1Total debt24.1Net cash (debt)51.9Shareholders’ equity58.1Debt to equity0.42Fiscal year 2022Cash39.1Total debt16.8Net cash (debt)22.3Shareholders’ equity38.6Debt to equity0.43Fiscal year 2023Cash6.1Total debt0.0Net cash (debt)6.1Shareholders’ equity6.3Debt to equity0.00Fiscal year 2024Cash1.1Total debt0.0Net cash (debt)1.1Shareholders’ equity2.1Debt to equity0.00Fiscal year 2025Cash1.4Shareholders’ equity2.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 81.1 70.9 61.7 79.7 115.1 76.1 39.1 6.1 1.1 1.4
Total debt n/a n/a n/a n/a 0.0 24.1 16.8 0.0 0.0 n/a
Net cash (debt) n/a n/a n/a n/a 115.1 51.9 22.3 6.1 1.1 n/a
Shareholders’ equity −77.3 −96.8 85.6 95.0 124.0 58.1 38.6 6.3 2.1 2.2
Debt to equity n/a n/a n/a n/a 0.00 0.42 0.43 0.00 0.00 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
6.9 6.4 0.1 n/a 0.0 0.4 2.9 0.0 0.0 0.0
Growth −6.9% −97.7% +634.2% −99.8% +100.0% −50.0%
157.8 45.1 34.1 38.3 52.7 49.6 25.0 16.3 0.4 1.4
14.4 14.8 19.9 19.5 27.7 27.6 13.1 12.2 4.5 2.9
−165.3 −53.5 −53.9 −57.9 −80.4 −77.5 −35.1 −34.3 −4.8 −4.2
Growth
n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.0
−165.3 −54.3 −53.1 −117.8 −80.0 −78.8 −37.7 −4.7 −4.7 −4.2
Growth
Per share
−1.32 −0.53 0.96 −0.70 −0.38 −0.37 −2.61 −21.97 −2.92 −2.20
−1.32 −0.53 0.96 −0.70 −0.38 −0.37 −2.61 −21.97 −2.92 −2.20
Growth −172.9%
130.4 136.9 143.5 168.0 209.6 214.4 14.5 1.6 1.6 1.9
130.4 136.9 143.7 168.0 209.6 214.4 14.5 1.6 1.6 1.9
Growth +5.0% +4.9% +16.9% +24.8% +2.3% −93.2% −88.9% +0.1% +21.7%

† The diluted share count jumps at 2022 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.